InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: justdafactss post# 164912

Wednesday, 05/12/2021 3:09:31 PM

Wednesday, May 12, 2021 3:09:31 PM

Post# of 233310

an Oncology company? Good question. Progenics, the folks that sold the failed molecule PRO 140 to Cytodyn is an oncology company but dropped PRO140/leronlimab---

As we have expanded our focus on oncology, we have terminated certain research efforts not within the Company’s oncology focus, and are working to out-license others, such as our PRO 140 and C.difficile programs.


That was back in 2012. At the time, Progenics sold their non-cancer drugs because they wanted to focus solely on cancer. PRO-140 was an HIV drug at the time. PRO-140 being used for cancer came after CytoDyn bought it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News